{"transactions":[{"id":981977,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T16:10:04.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":1218,"price":11.09,"value":13507.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":19126,"source":{"system":"sec-edgar","filing":"0001193125-25-306676","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000119312525306676/ownership.xml","form_type":"4"}},{"id":1043064,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T16:05:14.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":3225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date."}],"balance_after":3225,"derivative":{"exercise_price":15.36,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":3225},"source":{"system":"sec-edgar","filing":"0001193125-25-201318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000119312525201318/ownership.xml","form_type":"4"}},{"id":1050158,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T17:30:44.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":975,"price":13.86,"value":13513.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":17908,"source":{"system":"sec-edgar","filing":"0001193125-25-195091","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000119312525195091/ownership.xml","form_type":"4"}},{"id":1123259,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T16:05:13.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":1883,"price":7.17,"value":13501.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":4647,"source":{"system":"sec-edgar","filing":"0000950170-25-081609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000095017025081609/ownership.xml","form_type":"4"}},{"id":1223234,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-05T16:05:15.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":1536,"price":8.79,"value":13501.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":2764,"source":{"system":"sec-edgar","filing":"0000950170-25-033540","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000095017025033540/ownership.xml","form_type":"4"}},{"id":1339317,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-12-09T16:10:04.000Z","date":"2024-10-30","kind":"grant","planned":false,"acquired":true,"shares":41745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options were awarded in accordance with the MiNK Therapeutics Inc. 2021 Amended and Restated Equity Incentive Plan on October 30, 2024 and will vest in three equal annual installments on each of October 30, 2025, 2026 and 2027 (provided Dr. Kadlec maintains a service relationship with the company through each such vesting date)."}],"balance_after":41745,"derivative":{"exercise_price":0.72,"expiration_date":"2034-10-30","underlying":"Common Stock","underlying_shares":41745},"source":{"system":"sec-edgar","filing":"0000950170-24-134524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000095017024134524/ownership.xml","form_type":"4"}},{"id":1339316,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":72295,"kind":"person","name":"Kadlec Robert Peter","position":1,"cik":"0002047073","reported_name":"Kadlec Robert Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-09T16:10:04.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":12286,"price":0.73,"value":8968.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Dr. Kadlec was granted restricted stock unites (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU.  The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":12286,"source":{"system":"sec-edgar","filing":"0000950170-24-134524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2047073/000095017024134524/ownership.xml","form_type":"4"}}]}